These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 21267466)
1. Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. Tanner MJ; Welliver RC; Chen M; Shtutman M; Godoy A; Smith G; Mian BM; Buttyan R PLoS One; 2011 Jan; 6(1):e16027. PubMed ID: 21267466 [TBL] [Abstract][Full Text] [Related]
2. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells. Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968 [TBL] [Abstract][Full Text] [Related]
4. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer. Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787 [TBL] [Abstract][Full Text] [Related]
5. A human-derived prostate co-culture microtissue model using epithelial (RWPE-1) and stromal (WPMY-1) cell lines. Dent MP; Madnick SJ; Hall S; Vantangoli Policelli M; Bars C; Li H; Amin A; Carmichael PL; Martin FL; Boekelheide K Toxicol In Vitro; 2019 Oct; 60():203-211. PubMed ID: 31154061 [TBL] [Abstract][Full Text] [Related]
6. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
7. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430 [TBL] [Abstract][Full Text] [Related]
8. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517 [TBL] [Abstract][Full Text] [Related]
9. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase. Shigemura K; Isotani S; Wang R; Fujisawa M; Gotoh A; Marshall FF; Zhau HE; Chung LW Prostate; 2009 Jun; 69(9):949-55. PubMed ID: 19274665 [TBL] [Abstract][Full Text] [Related]
10. Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells. Wen J; Zhao Y; Li J; Weng C; Cai J; Yang K; Yuan H; Imperato-McGinley J; Zhu YS Prostate; 2013 Jul; 73(10):1069-81. PubMed ID: 23423946 [TBL] [Abstract][Full Text] [Related]
11. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation. Simanainen U; McNamara K; Gao YR; Handelsman DJ Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells. Gerdes MJ; Dang TD; Larsen M; Rowley DR Endocrinology; 1998 Aug; 139(8):3569-77. PubMed ID: 9681509 [TBL] [Abstract][Full Text] [Related]
13. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells. Mukherjee B; Mayer D Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894 [TBL] [Abstract][Full Text] [Related]
14. Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2. Hickman OJ; Smith RA; Dasgupta P; Rao SN; Nayak S; Sreenivasan S; Vyakarnam A; Galustian C Br J Cancer; 2016 May; 114(11):1235-42. PubMed ID: 27115470 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway. Jang YG; Go RE; Hwang KA; Choi KC J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279 [TBL] [Abstract][Full Text] [Related]
17. Androgen and prostatic stroma. Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998 [TBL] [Abstract][Full Text] [Related]
18. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364 [TBL] [Abstract][Full Text] [Related]
19. Aging up-regulates ARA55 in stromal cells, inducing androgen-mediated prostate cancer cell proliferation and migration. Zou Q; Cui D; Liang S; Xia S; Jing Y; Han B J Mol Histol; 2016 Jun; 47(3):305-15. PubMed ID: 27178620 [TBL] [Abstract][Full Text] [Related]
20. Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP. King KJ; Nicholson HD; Assinder SJ Prostate; 2006 Jan; 66(1):105-14. PubMed ID: 16114065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]